Can B Corp. (CANB) Research

Can B Corp. operates within the United States, specializing in the development, manufacturing, and sale of products derived from cannabidiol (CBD). Its extensive range of hemp-based CBD offerings includes oils, topical creams, moisturizers, isolates, gel capsules, spa items, concentrates, and various lifestyle products. Customers can purchase these goods through the company's official website, automated vending machines, and via partnerships with medical professionals. The firm markets its products under distinct brand names such as Canbiola, Nu Wellness, Seven Chakras, and Pure Leaf Oil. The company, which changed its name from Canbiola Inc. to Can B Corp. in February 2020, was founded in 2005 and is headquartered in Hicksville, New York.

Market snapshot

Symbol
CANB
Price
$0.02
Day change
+16.18%
Market cap
$985.9K
P/E ratio
-0.23x
52-week range
0.0077-0.1835
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic

Peer companies

  • AusCann Group Holdings Ltd (ACNNF)
  • CBD Global Sciences Inc. (CBDNF)
  • Pideka Group Inc. (CIMVF)
  • Entourage Health Corp. (ETRGF)
  • Irwin Naturals Inc. (IWINF)
  • Kallo Inc. (KALO)
  • Parnell Pharmaceuticals Holdings Ltd (PARNF)
  • Pure Extracts Technologies Corp. (PRXTF)

Open Can B Corp. (CANB) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.